Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during September 2025'.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec has submitted a routine regulatory filing to NSE disclosing the number of physical shares that were converted into electronic (demat) form during September 2025. Dematerialization allows shareholders to hold and trade their shares electronically instead of through paper certificates. The exact number of shares converted is not mentioned in the headline. This is a standard monthly compliance update required from listed companies.
This is a routine procedural disclosure with no direct impact on stock price or shareholder value. It reflects the ongoing shift of physical shares into demat form, which is normal market practice and does not indicate any corporate action or change in fundamentals.